Cargando…

SAT-LB064 Mitotane Induces Autophagy: A Mechanism to Promote Chemoresistance in Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is an orphan malignancy with dismal survival rates. Although recent large genomic studies have shed insight into underlying molecular mechanisms, there are currently no targeted therapies available. Autophagy is an important cellular process to promote survival in a lo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tompkins, Kenneth, Towers, Christina, Kar, Adwitiya, Zhang, Yu, Kiseljak-Vassiliades, Katja, Thorburn, Andrew, Wierman, Margaret
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Adrenal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551990/ http://dx.doi.org/10.1210/js.2019-SAT-LB064

Ejemplares similares

OR04-6 Comprehensive Profiling of the MELK Inhibitor OTSSP167's Action and Its Effect on Sensitization to Wee1 Inhibitor AZD1775 in a Spectrum of ACC Models
por: Bagby, Stacey, et al.
Publicado: (2022)

Insights From Targeted Genetic Analysis of 364 Adrenocortical Carcinomas
por: Pozdeyev, Nikita, et al.
Publicado: (2021)

Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer
por: Head, Lia, et al.
Publicado: (2019)

SUN-211 Active Steroid Hormone Synthesis Renders Adrenocortical Cells Highly Susceptible to Type II Ferroptosis Induction
por: Weigand, Isabel, et al.
Publicado: (2020)

SUN-337 Anti-tumorigenic Effects Of The Maternal Leucine Zipper Kinase (MELK) Inhibitor, OTSSP167, In Pre-clinical In Vivo Models Of Adrenocortical Carcinomas (ACC)
por: KAR, ADWITIYA, et al.
Publicado: (2019)

Investigating the Role of Cholesterol and Lipid Trafficking in Mitotane Resistance in Adrenocortical Carcinoma
por: Warde, Kate, et al.
Publicado: (2021)

SAT-158 New Data on High Prevalence and Time of Occurrence of New Onset Hypothyroidism Associated with Mitotane Therapy in a Cohort of Adrenocortical Cancer
por: Poirier, Jonathan, et al.
Publicado: (2020)

Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients
por: Terzolo, Massimo, et al.
Publicado: (2021)

SAT-LB36 Distinct Vitamin D Receptor DNA Methylation Profiles Are Associated With the Outcome of Pediatric Patients With Adrenocortical Tumors
por: Bueno, Ana Carolina, et al.
Publicado: (2020)

SUN-216 Investigating the Role of the Liver X Receptor in Potentiating Mitotane Therapy in Adrenocortical Carcinoma
por: Warde, Kate, et al.
Publicado: (2020)

MON-LB064 A Zebra of Adrenal Insufficiency: What Was Once Common Is Now Rare
por: Godfrey, Sean, et al.
Publicado: (2019)

SAT-LB44 WNT2B Regulates Adrenocortical Progenitor Cell Fate And Zona Glomerulosa Identity In Vivo
por: Little, Donald W, et al.
Publicado: (2020)

ODP597 Clinical case of uncomplicated pregnancy in a patient with adrenocortical carcinoma during treatment with mitotane
por: Beltsevich, Dmitry, et al.
Publicado: (2022)

SAT-LB34 Repressive Epigenetic Programs Reinforce Steroidogenic Differentiation and Wnt/β-Catenin Signaling in Aggressive Adrenocortical Carcinoma
por: Mohan, Dipika R, et al.
Publicado: (2020)

Leptomeningeal Metastasis from Adrenocortical Carcinoma: A Case Report
por: Schreiber, Anna R, et al.
Publicado: (2020)

Efficacy of Treatment With PARP Inhibitor and Immunotherapy for Aggressive Adrenocortical Carcinomawith Cushing’s Syndrome Refractory to Treatment With EDP Chemotherapy and Mitotane
por: Greb, Alexandra C, et al.
Publicado: (2021)

MON-LB037 Adrenocortical Carcinoma: A Case Report
por: Ebadi, Farha Naz, et al.
Publicado: (2020)

SAT313 Therapeutic Dosing Of Steroids In Patients On Mitotane
por: Pham, Christopher, et al.
Publicado: (2023)

SUN-350 Sterol-O-Acyl Transferase 1 Protein Expression Alone Is Not Sufficient to Predict Response to Mitotane Treatment in Adrenocortical Carcinoma
por: Weigand, Isabel, et al.
Publicado: (2019)

ODP049 Oncocytic adrenocortical carcinoma misdiagnosed as renal oncocytoma and use of urinary steroid profiling in disease monitoring after mitotane therapy
por: Wong, Cheuk Lik, et al.
Publicado: (2022)

SAT-LB43 Allgrove’s: A Syndrome for the “A”ges
por: Bailey, Richard, et al.
Publicado: (2020)

SAT-207 Adrenocortical Carcinoma in Untreated Congenital Adrenal Hyperplasia
por: David, Julia, et al.
Publicado: (2020)

SAT-LB40 Adrenalectomy - A Rural Teaching Hospital Experience
por: Shen, Alice S
Publicado: (2020)

SAT-LB068 Involvement of Serum Dehydroepiandrosterone Sulfate in Male Erythropoietic Activity
por: Harada, Ko, et al.
Publicado: (2019)

SAT-350 Comparative Proteomic Analysis of Various Forms of Bilateral Adrenocortical Hyperplasia
por: Berthon, Annabel, et al.
Publicado: (2019)

SAT-172 FDG PET/CT in Benign vs. Malignant Adrenocortical Tumors
por: He, Xin, et al.
Publicado: (2020)

SAT-173 SAMD9 (Sterile Alpha Motif Domain-Containing 9) Expression in Adrenocortical Tumors
por: Bueno, Ana C, et al.
Publicado: (2020)

SAT-179 Increased Telomere Length in Adrenocortical Tumors Is Associated with Abnormal Expression of Chromatin Remodelling Factors
por: Stecchini, Monica F, et al.
Publicado: (2020)

SAT-180 Adrenocortical Carcinoma - A Tertiary Center’s Recent 5-Year Experience
por: Ehrenwald, Michal, et al.
Publicado: (2020)

MON-LB061 Cushing Syndrome Due to an Adrenocortical Carcinoma in a Baby with Atypical Beckwith-Wiedemann Syndrome
por: Bereket, Abdullah, et al.
Publicado: (2019)

MON-LB042 A Rare Case of Adrenocortical Carcinoma Arising From Ectopic Adrenal Tissue in the Mesentery
por: George, Gemy M, et al.
Publicado: (2020)

SAT-LB062 Adrenal Sexual Dimorphism Is Abolished by Tissue-Targeted Deletion of the Androgen Receptor
por: Frucci, Emily, et al.
Publicado: (2019)

SAT-LB063 The ZFP36 Family of RNA-Binding Proteins Regulate Human Steroidogenesis
por: Wellman, Kimberly, et al.
Publicado: (2019)

SAT-354 Characterization of Cell Death Induced by SOAT1 Inhibition in Adrenocortical Carcinoma Cells
por: Weigand, Isabel, et al.
Publicado: (2019)

SAT-165 Sterol O-Acyl Transferase 1 as a Prognostic Marker of Adrenocortical Carcinoma
por: Lacombe, Amanda Meneses Ferreira, et al.
Publicado: (2020)

SAT-353 The Synthetic Vitamin D Analog EB1089 Restricts Adrenocortical Tumor Proliferation in NCI-H295 Xenograft Model
por: Bueno, Ana, et al.
Publicado: (2019)

THU609 Timeline For Undetectable Mitotane Plasma Levels In Adrenocortical Carcinoma Patients After Stopping Treatment
por: Younes, Nada, et al.
Publicado: (2023)

FRI199 Severe Hypertriglyceridemia And Acute Pancreatitis In A Patient With Adrenocortical Carcinoma (ACC) Taking Mitotane
por: Cortez, Briana Noel, et al.
Publicado: (2023)

SAT-178 Incidence, Patterns of Clinical Presentation, and Outcomes of Patients with Brain Metastasis Due to Adrenocortical Carcinoma
por: Amorim, Larissa Costa, et al.
Publicado: (2020)

PSAT096 Development and Validation of Mitotane Determination in Plasma Samples by LC-DAD
por: Lima-Valassi, Helena P, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r4tb9drbugacban3hvruibu0pd